Metraipolis › archive › dc_f3192d687441
Targeting VISTA as a novel immunotherapy for skin cancer — Europe PMC PMID:42824772
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42824772
- DOI
- 10.3389/fimmu.2026.1815113
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T10:21:52.163Z
- SHA-256 of the archived text
d9b5417f009f95fe8f945925129baaa642a90f52176140de6029259c7ae4a5ef- Stable URL of this page
https://metraipolis.com/documento/dc_f3192d687441
How to cite
Targeting VISTA as a novel immunotherapy for skin cancer — Europe PMC PMID:42824772 — Europe PMC (en), https://europepmc.org/article/MED/42824772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3192d687441 (Metraipolis archive dc_f3192d687441, sha256 d9b5417f009f95fe8f945925129baaa642a90f52176140de6029259c7ae4a5ef)
BibTeX
@misc{dcf3192d687441,
title = {Targeting VISTA as a novel immunotherapy for skin cancer — Europe PMC PMID:42824772},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42824772},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3192d687441; sha256 d9b5417f009f95fe8f945925129baaa642a90f52176140de6029259c7ae4a5ef},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824772. Agents can read the archived copy with the MCP tool read_document.